Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery

NCT00381901 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3400

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
GENETIC: polymorphism analysis
PROCEDURE: adjuvant therapy

Sponsor

National Cancer Institute, France